Abers, MS, Shandera, WX, Kass, JS (2014) Neurological and psychiatric adverse effects of antiretroviral drugs. CNS Drugs, 28: 131–45.
Abramowicz, M (2008) Drugs that may cause psychiatric symptoms. Medical Letters on Drugs and Therapeutics, 50: 100–3.
Alomar, MJ (2014) Factors affecting the development of adverse drug reactions. Saudi Pharmaceutical Journal, 22: 83-94.
Bechstein, WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant International, 13: 313–26.
Bersani, FS, Coviello, M, Imperatori, C et al (2015) Adverse psychiatric effects associated with herbal weight-loss products. BioMed Research International, 2015: 120679.
Borovaya, A, Olisova, O, Ruzicka, T et al (2013) Does isotretinoin therapy of acne cure or cause depression?
International Journal of Dermatology, 52: 1040–52.
Celano, CM, Freudenreich, O, Fernandez-Robles, C et al (2011) Depressogenic effects of medications: a review. Dialogues in Clinical Neurosciences, 13: 103–25.
Cheslack-Postava, K, Keyes, KM, Lowe, SR et al (2015) Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. Archives of Women's Mental Health, 18: 103–11.
Desai, AK (2004) Psychotropic side effects of commonly prescribed medications in the elderly. Primary Psychiatry, 11: 27-34.
Edwards, IR, Aronson, JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet, 356: 1255–9.
Ernst, E (2003) Serious psychiatric and neurological adverse effects of herbal medicines – a systematic review. Acta Psychiatrica Scandinavica, 108: 83-91.
Ernst, E (2007) Herbal remedies for depression and anxiety. Advances in Psychiatric Treatment, 13: 312–6.
Ferrando, SJ, Levenson, JL, Owen, JA (2010) Clinical Manual of Psychopharmacology in the Medically Ill. American Psychiatric Publishing.
Gordon, JL, Girdler, SS (2014) Hormone replacement therapy in the treatment of perimenopausal depression. Current Psychiatry Reports, 6: 517.
Heinrich, TW, Marcangelo, M (2009) Psychiatric issues in solid organ transplantation. Harvard Review of Psychiatry, 17: 398-406.
Holland, JC, Andersen, B, Breitbart, WS et al (2013) Distress management: clinical practice guidelines in oncology. Journal of National Comprehensive Cancer Network, 11: 190-209.
Holvey, C, Connolly, A, Taylor, D (2010) Psychiatric side effects of non-psychiatric drugs. British Journal of Hospital Medicine, 71: 432–6.
Hubbard, JR, Levenson, JL, Patrick, GA (1991) Psychiatric side effects associated with the ten most commonly dispensed prescription drugs: a review. Journal of Family Practice, 33: 177–86.
Huffman, JC, Stern, TA (2007) Neuropsychiatric consequences of cardiovascular medications. Dialogues in Clinical Neurosciences, 9: 29-45.
Janelsins, MC, Kohli, S, Mohile, SG et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Seminars in Oncology, 38: 431–8.
Judd, LL, Schettler, PJ, Brown, ES et al (2014) Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. American Journal of Psychiatry, 171: 1045–51.
Kenna, H, Poon, AW, De Los Angeles, CP et al (2011) Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry and Clinical Neurosciences, 65: 549–60.
Kersey, RD, Elliot, DL, Goldberg, L et al (2012) National athletic trainers' association position statement: anabolic-androgenic steroids. Journal of Athletic Training, 47: 567–88.
Keyes, KM, Cheslack-Postava, K, Westhoff, C et al (2013) Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. American Journal of Epidemiology, 178: 1378–88.
Mehta, RD, Roth, AJ (2015) Psychiatric considerations in the oncology setting. CA: A Cancer Journal for Clinicians, 65: 299-314.
Meyer, RE, Salzman, C, Youngstrom, EA et al (2010) Suicidality and risk of suicide – definition, drug safety concerns, and a necessary target for drug development: a consensus statement. Journal of Clinical Psychiatry, 71: e1-21.
Myint, AM, Schwarz, MJ, Steinbusch, HW et al (2009) Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disease, 24: 55-68.
Onder, G, Pellicciotti, F, Gambassi, G et al (2004) NSAID-related psychiatric adverse events: who is at risk?
Drugs, 64: 2619–27.
Pachi, A, Bratis, D, Moussas, G et al (2013) Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberculosis Research and Treatment, 2013: 1-37.
Parker, C (2012) Psychiatric effects of drugs for other disorders. Medicine, 40: 691–5.
Perucca, P, Gilliam, F (2012) Adverse effects of antiepileptic drugs. Lancet Neurology, 11: 792-802.
Raison, CL, Demetrashvili, M, Capuron, L et al (2005) Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs, 19: 105–23.
Raja, M (2012) Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's disease and other disorders. Current Drug Safety, 7: 63-75.
Rudorfer, MV, Hillefors, M (2012) Assessing psychiatric adverse effects during clinical drug development. Pharmaceutical Medicine, 26: 363–94.
Sidhu, KS, Balon, R (2008) Watch for nonpsychotropics causing psychiatric side effects. Current Psychiatry, 7(4): 61–4, 68–74.
Simons, FE, Simons, KJ (2008) H1 antihistamines: current status and future directions. World Allergy Organization Journal, 1: 145–55.
Suvada, J (2013) Neuropathic and neurocognitive complications of antiretroviral therapy among HIV-infected patients. Neuro Endocrinology Letters, 34 (suppl 1): 5-11.
Tango, RC (2003) Psychiatric side effects of medications prescribed in internal medicine. Dialogues in Clinical Neurosciences, 5: 155–65.
Turjanski, N, Lloyd, G (2005) Psychiatric side-effects of medications: recent developments. Advances in Psychiatric Treatment, 11: 58-70.
Warrington, TP, Bostwick, JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceedings, 81: 1361–7.
Wefel, JS, Kesler, SR, Noll, KR et al (2015) Clinical characteristics, pathophysiology, and management of non-central nervous system cancer-related cognitive impairment in adults. CA: Cancer Journal for Clinicians
Zahodne, LB, Fernandez, HH (2008) Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs & Aging, 25: 665–82.